Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic-Reference-Cited by-同舟云学术

Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic

Published:2020-09 Issue: Volume:89 Page:102067
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Vilariño N.,Bruna J.,Bosch-Barrera J.^ORCID,Valiente M.,Nadal E.^ORCID

Funder

Department of Health

Government of Catalonia

Bristol-Myers Squibb

Melanoma Research Alliance

Fundación Ramón Areces

Bosch

Health Research

Departament de Salut, Generalitat de Catalunya

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference85 articles.

1. The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer;Peters;Cancer Treat Rev,2016

2. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System;Barnholtz-Sloan;J Clin Oncol,2004

3. Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO);Soffietti;Neuro Oncol,2017

4. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial;Chang;Lancet Oncol,2009

5. Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07–01);Barlesi;Ann Oncol,2011

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reactive astrocytes promote tumor progression by up-regulating tumor protocadherin 1 expression in lung cancer brain metastasis;Biochemical and Biophysical Research Communications;2024-11

2. The role of immunotherapy in patients with lung cancer and brain metastases: a narrative review of the literature;Monaldi Archives for Chest Disease;2024-07-26

3. Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR‐mutated, advanced non‐small cell lung cancer: data from a randomized phase III trial (AENEAS);Cancer Communications;2024-07-17

4. Brain Metastasis from EGFR‐Mutated Non‐Small Cell Lung Cancer: Secretion of IL11 from Astrocytes Up‐Regulates PDL1 and Promotes Immune Escape;Advanced Science;2024-05-02

5. Exploring the Molecular Tumor Microenvironment and Translational Biomarkers in Brain Metastases of Non-Small-Cell Lung Cancer;International Journal of Molecular Sciences;2024-02-07